Use access key #2 to skip to page content.
$68.55 0.18 (0.26%)
5/13/2008 4:02 PM

Genentech, Inc. (DNA)

CAPS Rating:
****

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating DNA

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

1567 Outperforms
88 Underperforms
 

All-Stars

406 Outperforms
19 Underperforms
 

Wall Street

20 Outperforms
0 Underperforms
 

Players bullish on DNA are also bullish on:

Players bearish on DNA are also bearish on:

Ticker Tags

Drug Manufacturers - Major (27), Mega Cap (146), Rule Breakers Universe (161), Dermatology (7), San Francisco (3), California (41), It's a Noun! (82), Biotechnology (291)
Suggest a tag

Genentech, Inc. At A Glance

Current Price: $68.55
Last Trade Time: 5/13/2008 4:02 PM
Open: $68.74
Previous Close: $68.37
Daily Range: $68.20 - $69.23
52-Week Range: $65.35 - $82.20
Volume: 2,742,876
Market Cap: $71.85B
P/E Ratio: 23.66
Compare Our Special Broker Offers!

Stock Trends

DNA VS S&P 500 (SPY)

DNA 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for DNA

More Headlines...

Top Bull Pitch

Recs

6

Genentech, Inc. (DNA)

Avatar Mojo007 (< 20) Submitted: 2/24/08 8:42 PM

Genentech is a great biotech company in terms of growth and demand for existing products. To my surprise, Avasin was just approved by the FDA for breast cancer treatment. With over half of eligible lung cancer patients already taking this drug, and strong pricing power, this stock should be a rewa...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Genentech, Inc. (DNA)

Avatar justahistorian (84.81) Submitted: 2/26/07 12:58 PM

Genentech has some outstanding drugs, perhaps none better for revenue than Avastin. The drug has demonstrated efficacy in a number of different cancers and clinical trials to date have not shown that the drug should ever be stopped. Add to that the drug's cost $55,000/year for the most common use, a...More

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 253 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (DNA)

Avatar shawp (< 20) Submitted: 5/11/08 10:41 AM : Outperform Start Price: $68.50 DNA Score: -0.81

great company , see this at $100 in years time .

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DNA)

Avatar medianline (< 20) Submitted: 5/08/08 11:48 PM : Outperform Start Price: $68.01 DNA Score: -0.71

Weekly and Daily Stochastics oversold.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DNA)

Avatar swingtrader930 (< 20) Submitted: 5/07/08 12:23 PM : Outperform Start Price: $68.20 DNA Score: 1.04

DNA is trading at about a 40% discount based on its 18% CAGR over the last 10 years. It has currently found support on it's 50-month moving average. This is a good place to test the waters. It could possible drop through $60 but I dont anticipate it would stay there very long. The company also this month announced a buy back which should help support it at its current level.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DNA)

Avatar brianjac (31.54) Submitted: 5/07/08 7:35 AM : Outperform Start Price: $68.24 DNA Score: 1.50

Solid company with steadily increasing earnings, solid balance sheet, and great pipeline of potential blockbuster drugs that just got beaten up by bad news. Back at 80 very soon.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DNA)

Avatar brianpkbs (34.37) Submitted: 5/03/08 11:12 PM : Outperform Start Price: $67.25 DNA Score: 2.34

Buy this stock now because its going no where but up from here.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 253 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 20 of 20  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRodmanRen < 20 02/25/08 Outperform NS $78.12-12.25%+3.64%-15.90
TrackZacks 93.36 02/25/08 Outperform 3M $77.96-12.07%+2.29%-14.36 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 87.14 12/31/07 Outperform NS $67.07+2.21%-3.92%+6.13 Toggle the visibility of 60-Second Pitch and replies
TrackFortune2008 51.33 12/14/07 Outperform 1Y $68.43+0.18%-4.04%+4.21
TrackBroadpointC 27.73 12/06/07 Outperform NS $65.98+3.90%-5.86%+9.76
TrackCowenandCo 65.89 12/06/07 Outperform NS $67.62+1.38%-5.48%+6.86
TrackJimCramer 80.91 11/13/07 Outperform 3W $73.78-7.09%-5.13%-1.96
TrackEdwardOwens 65.71 09/30/07 Outperform NS $78.02-12.14%-7.93%-4.21 Toggle the visibility of 60-Second Pitch and replies
TrackUBS 93.79 09/21/07 Outperform NS $80.18-14.50%-8.01%-6.50
TrackDeutscheSec 89.24 06/08/07 Outperform NS $75.80-9.56%-6.03%-3.53
Track2007Wired40 97.87 03/27/07 Outperform 1Y $82.55-16.96%-1.58%-15.38
TrackMichaelSivy 52.70 03/20/07 Outperform 1Y $82.06-16.46%-0.35%-16.12
TrackTWeisel < 20 02/22/07 Outperform NS $85.73-20.04%-3.48%-16.56
TrackLazardCapit < 20 10/12/06 Outperform NS $83.56-17.96%+3.65%-21.61
TrackPiperJaff 68.90 10/12/06 Outperform NS $83.56-17.96%+3.65%-21.61
TrackCarisandCo < 20 09/18/06 Outperform NS $79.00-13.23%+6.61%-19.84
TrackStifel 87.16 09/14/06 Outperform NS $79.30-13.56%+6.46%-20.01
TrackRWBaird 57.20 09/12/06 Outperform NS $78.62-12.81%+7.60%-20.41
TrackRBCCapMkts 89.84 09/12/06 Outperform NS $78.62-12.81%+7.60%-20.41
TrackJanney < 20 08/18/06 Outperform NS $82.30-16.71%+7.90%-24.61
Track2006Wired40 96.84 06/27/06 Outperform 1Y $77.89-11.99%+13.40%-25.40

Results 1 - 20 of 20  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners